Evidence map›Paper›PMID 42694210›Full record

ArticleFrontiers in microbiology2026

Genome-guided isolation and characterization of a novel bacteriophage infecting

Julia Oberdorfer, Jasmin Tesani, Thaysa Leite Tagliaferri, Simon Maurice Schmitz, Eva Miriam Buhl, Florian Kraft, Alex Krüttgen, Hans-Peter Horz

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julia OberdorferInstitute of Medical Microbiology, RWTH Aachen University Hospital, Aachen, Germany.
Jasmin TesaniInstitute of Medical Microbiology, RWTH Aachen University Hospital, Aachen, Germany.
Thaysa Leite TagliaferriInstitute of Medical Microbiology, RWTH Aachen University Hospital, Aachen, Germany.
Simon Maurice SchmitzInstitute of Medical Microbiology, RWTH Aachen University Hospital, Aachen, Germany.
Eva Miriam BuhlElectron Microscopy Facility, RWTH Aachen University Hospital, Aachen, Germany.
Florian KraftCenter for Human Genetics and Genomic Medicine, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
Alex KrüttgenLaboratory Diagnostic Center, RWTH Aachen University Hospital, Aachen, Germany.
Hans-Peter HorzInstitute of Medical Microbiology, RWTH Aachen University Hospital, Aachen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have isolated and characterized a novel bacteriophage termed Jab, with lytic activity against multidrug-resistant clinical isolates of

Indexed as

Escherichia colilytic phagenew genusouter membrane vesiclesVequintavirinae

Identifiers

PMID42694210
PMCPMC13538427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.